Glen Eagle Advisors, LLC Embecta Corp. Transaction History
Glen Eagle Advisors, LLC
- $650 Billion
- Q2 2025
A detailed history of Glen Eagle Advisors, LLC transactions in Embecta Corp. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 258 shares of EMBC stock, worth $3,441. This represents 0.0% of its overall portfolio holdings.
Number of Shares
258
Previous 175
47.43%
Holding current value
$3,441
Previous $2.23 Million
12.06%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding EMBC
# of Institutions
418Shares Held
58.5MCall Options Held
26.7KPut Options Held
74K-
Black Rock Inc. New York, NY9.19MShares$123 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$72.9 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO5.2MShares$69.3 Million0.03% of portfolio
-
River Road Asset Management, LLC3.24MShares$43.2 Million0.43% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.75MShares$36.7 Million0.61% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $772M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...